PMID- 31927718 OWN - NLM STAT- MEDLINE DCOM- 20210122 LR - 20210122 IS - 1573-6830 (Electronic) IS - 0272-4340 (Linking) VI - 40 IP - 6 DP - 2020 Aug TI - Effect of Escitalopram on Serum GDNF and BDNF Levels and 5-HT Level of Brain Tissue of Obsessive-Compulsive Disorder Rats. PG - 991-997 LID - 10.1007/s10571-020-00788-4 [doi] AB - The present study aims to discuss the effect of escitalopram in glial cell line-derived neurotrophic factor (GDNF), brain-derived neurotrophic factor (BDNF) levels, and 5-Hydroxytryptamine (5-HT) in obsessive-compulsive disorder rats. A total of 42 rats were divided into three groups randomly: control group (n = 14), model group (n = 14) (obsessive-compulsive disorder group), and escitalopram group (n = 14) (model + obsessive-compulsive disorder group + escitalopram treatment). The open-field method was used to test the rat behavior, enzyme-linked immunosorbent assay (ELISA) was used to determine the serum GDNF and BDNF levels. In addition, Western blot was used to determine the brain tissue protein levels of GDNF and BDNF and high-performance liquid chromatography + electrochemistry method to determine the 5-HT level of brain tissue. Visiting place was changed, rotational frequency and fixed duration enhanced in escitalopram group compared to model group (P < 0.05). Besides, GDNF and BDNF levels of serum and brain tissue were decreased in model group and escitalopram group compared to control group (P < 0.05), while GDNF and BDNF levels of serum and brain tissue were increased in escitalopram group compared to model group (P < 0.05). Moreover, the 5-HT level of brain tissue in escitalopram group was higher than that in model group (P < 0.05). Escitalopram could increase GDNF and BDNF levels and 5-HT content in serum and brain tissue in obsessive-compulsive disorder rats, which contributes to a function on the treatment of obsessive-compulsive disorder. FAU - Guo, Hui-Rong AU - Guo HR AUID- ORCID: 0000-0002-1167-0443 AD - Department of Psychiatry, The First Affiliated Hospital of Zhengzhou University, No. 1 of Jianshe East Road, Erqi District, Zhengzhou, 450052, China. ruirongguo123@163.com. FAU - Huang, Bai-Ling AU - Huang BL AD - Department of Psychiatry, The First Affiliated Hospital of Zhengzhou University, No. 1 of Jianshe East Road, Erqi District, Zhengzhou, 450052, China. FAU - Wang, Ya-Li AU - Wang YL AD - Department of Psychiatry, The First Affiliated Hospital of Zhengzhou University, No. 1 of Jianshe East Road, Erqi District, Zhengzhou, 450052, China. FAU - Zhang, Yan-Yan AU - Zhang YY AD - Department of Psychiatry, The First Affiliated Hospital of Zhengzhou University, No. 1 of Jianshe East Road, Erqi District, Zhengzhou, 450052, China. FAU - Ma, Quan-Gang AU - Ma QG AD - Department of Psychiatry, The First Affiliated Hospital of Zhengzhou University, No. 1 of Jianshe East Road, Erqi District, Zhengzhou, 450052, China. FAU - Lv, Pei-Pei AU - Lv PP AD - Department of Psychiatry, The First Affiliated Hospital of Zhengzhou University, No. 1 of Jianshe East Road, Erqi District, Zhengzhou, 450052, China. FAU - Ren, Yu-Ming AU - Ren YM AD - Basic Medical School, Xinxiang Medical University, No.1 Jinsui Avenue, Hongqi District, XinXiang, 453003, China. LA - eng GR - 172102310578/Science and Technology Department of Henan Province (CN)/ PT - Journal Article DEP - 20200111 PL - United States TA - Cell Mol Neurobiol JT - Cellular and molecular neurobiology JID - 8200709 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Glial Cell Line-Derived Neurotrophic Factor) RN - 0DHU5B8D6V (Citalopram) RN - 333DO1RDJY (Serotonin) SB - IM MH - Animals MH - Behavior, Animal/drug effects MH - Brain/*metabolism MH - Brain-Derived Neurotrophic Factor/*blood MH - Citalopram/*pharmacology MH - Glial Cell Line-Derived Neurotrophic Factor/*blood MH - Obsessive-Compulsive Disorder/*blood MH - Rats, Wistar MH - Serotonin/*metabolism OTO - NOTNLM OT - Brain-derived neurotrophic factor OT - Escitalopram OT - Glial cell-derived neurotrophic factor OT - Obsessive-compulsive disorder OT - Serotonin EDAT- 2020/01/14 06:00 MHDA- 2021/01/23 06:00 CRDT- 2020/01/14 06:00 PHST- 2019/09/20 00:00 [received] PHST- 2020/01/04 00:00 [accepted] PHST- 2020/01/14 06:00 [pubmed] PHST- 2021/01/23 06:00 [medline] PHST- 2020/01/14 06:00 [entrez] AID - 10.1007/s10571-020-00788-4 [pii] AID - 10.1007/s10571-020-00788-4 [doi] PST - ppublish SO - Cell Mol Neurobiol. 2020 Aug;40(6):991-997. doi: 10.1007/s10571-020-00788-4. Epub 2020 Jan 11.